Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NRSN | US
-0.03
-4.11%
Healthcare
Biotechnology
30/06/2024
10/04/2026
0.70
0.71
0.73
0.68
NeuroSense Therapeutics Ltd. a clinical-stage biotechnology company focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya Israel.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
79.7%1 month
64.5%3 months
76.6%6 months
84.7%-
-
4.15
-0.02
0.02
-1.16
-
-
-11.69M
13.87M
13.87M
-
-
-
-
-494.84
1.04
1.83
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.18
Range1M
0.42
Range3M
0.47
Rel. volume
0.52
Price X volume
66.38K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | VTGN | Biotechnology | 0.5604 | 15.16M | 0.81% | n/a | 1.90% |
| Lexaria Bioscience Corp | LEXX | Biotechnology | 0.91 | 14.39M | 0.56% | n/a | 1.41% |
| Anebulo Pharmaceuticals Inc. Common Stock | ANEB | Biotechnology | 0.54 | 14.00M | n/a | 0.00% | |
| XTL Biopharmaceuticals Ltd | XTLB | Biotechnology | 2.3701 | 12.91M | -4.43% | n/a | 0.00% |
| Cocrystal Pharma Inc | COCP | Biotechnology | 1.25 | 12.72M | -12.59% | n/a | 10.24% |
| Genenta Science S.p.A | GNTA | Biotechnology | 0.669 | 12.19M | -1.47% | n/a | 0.00% |
| JSPR | JSPR | Biotechnology | 0.8023 | 12.12M | -2.59% | n/a | 2.31% |
| CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 1 | 11.54M | 0.00% | n/a | 3.98% |
| HOOKIPA Pharma Inc | HOOK | Biotechnology | 1.13 | 11.18M | -0.88% | n/a | 5.69% |
| GeoVax Labs Inc | GOVX | Biotechnology | 1.23 | 10.49M | 6.03% | n/a | -6.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.601 | 11.61M | -7.68% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.34 | 3.42M | 3.08% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2536 | 2.41M | -15.10% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | 7.18% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.006 | 553.29K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.16 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.15 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 76.59 | - | Par |
| Debt to Equity | -0.02 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 13.87M | - | Emerging |